We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Healthcare company INS Bioscience Bhd (INSbio), encouraged by the sales of its blood sugar lowering herbal product, Insupro forte, is teaming up with the National Diabetes Institute (Nadi) in an effort to enhance awareness on diabetes.
Banyu Pharmaceutical has obtained additional approval for NU-LOTAN Tablet 25mg/50mg (losartan potassium), its proprietary agent for treating hypertension, from the Ministry of Health, Labor and Welfare.
Israel's Teva Pharmaceutical reported that the U.S. FDA has granted tentative approval for the company's abbreviated new drug application (ANDA) to market its generic version of Wyeth's Protonix (pantoprazole sodium) delayed release (DR) tablets in 20 mg and 40 mg.
The combination of dual antiplatelet therapy with clopidogrel and low-dose aspirin did not show any significant benefit in patients with symptomatic atherothrombosis, according to a study published in the New England Journal of Medicine.
Swiss pharmaceutical company Roche has submitted a biological license application (BLA) to the U.S. FDA to market CERA for the treatment of anemia associated with chronic kidney disease in patients both on dialysis and not on dialysis.
Pfizer Japan, the Japanese subsidiary of the U.S.-based drugmaker, has received approval from Japan's Ministry of Health, Labor and Welfare for an additional indication for 600 mg Zyvox (linezolid) tablets and injection, the company's proprietary antibacterial agent, Pfizer reported.
Big pharmaceutical companies such as Roche and Novartis are increasingly outsourcing the research and development of new drugs to smaller biotech firms.
Angolan health authorities have launched a malaria-control program using a new fast-acting anti- malarial drug in an attempt to combat the infectious disease.